Oxidative Status and Its Relation with Insulin Resistance in Young Non-obese Women with Polycystic Ovary Syndrome

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2011 Apr 28

PMID 21521935

Citations 20

Authors

Z Kurdoglu

H Ozkol

Y Tuluce

I Koyuncu

Affiliations

Soon will be listed here.

Abstract

Background: Oxidative stress may play a role in the pathophysiology of polycystic ovary syndrome (PCOS). Insulin resistance (IR) also can be found in young non-obese women with PCOS. Hyperglycemia may increase reactive oxygen species production and decrease antioxidant levels.

Aim: To investigate oxidative status and its relation with IR in young non-obese patients with PCOS.

Material/subjects And Methods: Thirty-one patients with hyperinsulinemic (no.=13) and normoinsulinemic (no.=18) PCOS and 29 healthy controls were included in this study. Serum levels of glucose, insulin, gonadotropins, total testosterone, DHEAS, SHBG, 2-h plasma glucose on oral glucose tolerance test, malondialdehyde (MDA), protein carbonyl (PC), reduced glutathione (GSH), β carotene, vitamin A, C, E and the enzyme activities of catalase and glutathione S-transferase (GST), IR [by homeostasis model assessment (HOMA)-IR], and β cell function [by HOMA-B] were assessed.

Results: Serum glucose, insulin, total testosterone, DHEAS, HOMA-IR levels, and LH/FSH ratios were higher in young non-obese women with PCOS. Serum MDA and PC levels were also higher but GSH, vitamin C and E levels, and GST enzyme activity were lower in these women than in healthy controls, independently of the status of IR (p<0.05).

Conclusions: Oxidative stress characterized by increased oxidants and decreased antioxidant levels which are independent of IR may be involved in the pathogenesis of PCOS in young non-obese women.

Citing Articles

Evaluation of folliculogenesis and oxidative stress parameters in type 1 diabetes mellitus women with different glycemic profiles.

Tiselko A, Misharina E, Yarmolinskaya M, Milyutina Y, Zalozniaia I, Korenevsky A Endocrine. 2024; 85(3):1131-1140.

PMID: 38842765 DOI: 10.1007/s12020-024-03805-4.

Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome.

Gao Y, Zou Y, Wu G, Zheng L Front Med (Lausanne). 2023; 10:1193749.

PMID: 37448805 PMC: 10336225. DOI: 10.3389/fmed.2023.1193749.

Antioxidant Defense Expressed as Glutathione Status and Keap1-Nrf2 System Action in Relation to Anthropometric Parameters and Body Composition in Young Women with Polycystic Ovary Syndrome.

Chelchowska M, Jurczewska J, Gajewska J, Mazur J, Szostak-Wegierek D, Rudnicka E Antioxidants (Basel). 2023; 12(3).

PMID: 36978978 PMC: 10045817. DOI: 10.3390/antiox12030730.

Exploring the Mechanism of Wenshen Huatan Quyu Decotion for PCOS Based on Network Pharmacology and Molecular Docking Verification.

Guo X, Xu Y, Sun J, Wang Q, Kong H, Zhong Z Stem Cells Int. 2022; 2022:3299091.

PMID: 36071733 PMC: 9441343. DOI: 10.1155/2022/3299091.

Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values.

Niepsuj J, Franik G, Madej P, Piwowar A, Bizon A Biomedicines. 2022; 10(7).

PMID: 35884870 PMC: 9328171. DOI: 10.3390/biomedicines10071564.

References

Azziz R . Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril. 2003; 80(2):252-4. DOI: 10.1016/s0015-0282(03)00735-0. View

Levine R, Garland D, Oliver C, Amici A, Climent I, Lenz A . Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990; 186:464-78. DOI: 10.1016/0076-6879(90)86141-h. View

Kuscu N, Var A . Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009; 88(5):612-7. DOI: 10.1080/00016340902859315. View

Karadeniz M, Erdogan M, Tamsel S, Zengi A, Alper G, Caglayan O . Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances. Exp Clin Endocrinol Diabetes. 2008; 116(4):231-5. DOI: 10.1055/s-2007-992154. View

Rodrigues J, Dib L, Ferriani R, Jordao Junior A, Navarro P . [Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls]. Rev Bras Ginecol Obstet. 2010; 32(3):118-25. DOI: 10.1590/s1516-84842010005000079. View

Mannervik B, Guthenberg C . Glutathione transferase (human placenta). Methods Enzymol. 1981; 77:231-5. DOI: 10.1016/s0076-6879(81)77030-7. View

Uzel N, Sivas A, Uysal M, Oz H . Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res. 1987; 19(2):89-90. DOI: 10.1055/s-2007-1011748. View

Chang R, Nakamura R, Judd H, Kaplan S . Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983; 57(2):356-9. DOI: 10.1210/jcem-57-2-356. View

Fenkci V, Fenkci S, Yilmazer M, Serteser M . Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003; 80(1):123-7. DOI: 10.1016/s0015-0282(03)00571-5. View

10.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

11.

Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114(12):1752-61. PMC: 535065. DOI: 10.1172/JCI21625. View

12.

Telci A, Cakatay U, Kayali R, Erdogan C, Orhan Y, Sivas A . Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res. 2000; 32(1):40-3. DOI: 10.1055/s-2007-978584. View

13.

Verit F, Erel O . Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest. 2008; 65(4):233-9. DOI: 10.1159/000113046. View

14.

Rajendran S, Willoughby S, Chan W, Liberts E, Heresztyn T, Saha M . Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis. 2008; 204(2):509-14. DOI: 10.1016/j.atherosclerosis.2008.09.010. View

15.

Hegde K, Henein M, Varma S . Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies. Diabetes Obes Metab. 2003; 5(2):113-9. DOI: 10.1046/j.1463-1326.2003.00251.x. View

16.

Suzuki J, Katoh N . A simple and cheap methods for measuring serum vitamin A in cattle using only a spectrophotometer. Nihon Juigaku Zasshi. 1990; 52(6):1281-3. DOI: 10.1292/jvms1939.52.1281. View

17.

Behrman H, Preston S, Aten R, Rinaudo P, Zreik T . Hormone induction of ascorbic acid transport in immature granulosa cells. Endocrinology. 1996; 137(10):4316-21. DOI: 10.1210/endo.137.10.8828491. View

18.

Glintborg D, Andersen M . An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2010; 26(4):281-96. DOI: 10.3109/09513590903247873. View

19.

Lee A, Chung S . Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999; 13(1):23-30. DOI: 10.1096/fasebj.13.1.23. View

20.

Palacio J, Iborra A, Ulcova-Gallova Z, Badia R, Martinez P . The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol. 2006; 144(2):217-22. PMC: 1809652. DOI: 10.1111/j.1365-2249.2006.03061.x. View